vs
Kiniksa Pharmaceuticals International, plc（KNSA）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
Kiniksa Pharmaceuticals International, plc的季度营收约是ROGERS CORP的1.0倍（$202.1M vs $200.5M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs 2.2%，领先4.8%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 5.2%），Kiniksa Pharmaceuticals International, plc自由现金流更多（$53.3M vs $1.1M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs -3.3%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
KNSA vs ROG — 直观对比
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $200.5M |
| 净利润 | $14.2M | $4.5M |
| 毛利率 | 89.6% | 32.2% |
| 营业利润率 | 9.8% | — |
| 净利率 | 7.0% | 2.2% |
| 营收同比 | 65.0% | 5.2% |
| 净利润同比 | 259.8% | 421.4% |
| 每股收益（稀释后） | $0.18 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $200.5M | ||
| Q4 25 | $202.1M | $201.5M | ||
| Q3 25 | $180.9M | $216.0M | ||
| Q2 25 | $156.8M | $202.8M | ||
| Q1 25 | $137.8M | $190.5M | ||
| Q4 24 | $122.5M | $192.2M | ||
| Q3 24 | $112.2M | $210.3M | ||
| Q2 24 | $108.6M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $14.2M | $4.6M | ||
| Q3 25 | $18.4M | $8.6M | ||
| Q2 25 | $17.8M | $-73.6M | ||
| Q1 25 | $8.5M | $-1.4M | ||
| Q4 24 | $-8.9M | $-500.0K | ||
| Q3 24 | $-12.7M | $10.7M | ||
| Q2 24 | $-3.9M | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | 89.6% | 31.5% | ||
| Q3 25 | 88.8% | 33.5% | ||
| Q2 25 | 88.1% | 31.6% | ||
| Q1 25 | 87.0% | 29.9% | ||
| Q4 24 | 85.4% | 32.1% | ||
| Q3 24 | 82.1% | 35.2% | ||
| Q2 24 | 88.7% | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 3.5% | ||
| Q3 25 | 13.3% | 7.3% | ||
| Q2 25 | 12.9% | -33.3% | ||
| Q1 25 | 9.6% | -0.2% | ||
| Q4 24 | -15.7% | -6.6% | ||
| Q3 24 | -8.6% | 6.9% | ||
| Q2 24 | -0.1% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 7.0% | 2.3% | ||
| Q3 25 | 10.2% | 4.0% | ||
| Q2 25 | 11.4% | -36.3% | ||
| Q1 25 | 6.2% | -0.7% | ||
| Q4 24 | -7.3% | -0.3% | ||
| Q3 24 | -11.3% | 5.1% | ||
| Q2 24 | -3.6% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.18 | $0.20 | ||
| Q3 25 | $0.23 | $0.48 | ||
| Q2 25 | $0.23 | $-4.00 | ||
| Q1 25 | $0.11 | $-0.08 | ||
| Q4 24 | $-0.11 | $-0.04 | ||
| Q3 24 | $-0.18 | $0.58 | ||
| Q2 24 | $-0.06 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $567.6M | $1.2B |
| 总资产 | $763.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $195.8M | ||
| Q4 25 | $414.1M | $197.0M | ||
| Q3 25 | $352.1M | $167.8M | ||
| Q2 25 | $307.8M | $157.2M | ||
| Q1 25 | $268.3M | $175.6M | ||
| Q4 24 | $243.6M | $159.8M | ||
| Q3 24 | $223.8M | $146.4M | ||
| Q2 24 | $218.8M | $119.9M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $567.6M | $1.2B | ||
| Q3 25 | $535.4M | $1.2B | ||
| Q2 25 | $495.0M | $1.2B | ||
| Q1 25 | $457.5M | $1.3B | ||
| Q4 24 | $438.4M | $1.3B | ||
| Q3 24 | $437.0M | $1.3B | ||
| Q2 24 | $435.1M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $763.6M | $1.4B | ||
| Q3 25 | $712.3M | $1.4B | ||
| Q2 25 | $661.1M | $1.5B | ||
| Q1 25 | $599.3M | $1.5B | ||
| Q4 24 | $580.6M | $1.5B | ||
| Q3 24 | $555.3M | $1.5B | ||
| Q2 24 | $542.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $53.3M | $1.1M |
| 自由现金流率自由现金流/营收 | 26.4% | 0.5% |
| 资本支出强度资本支出/营收 | 0.3% | 2.3% |
| 现金转化率经营现金流/净利润 | 3.80× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $136.4M | $70.1M |
8季度趋势，按日历期对齐
| Q1 26 | — | $5.8M | ||
| Q4 25 | $53.9M | $46.9M | ||
| Q3 25 | $33.7M | $28.9M | ||
| Q2 25 | $28.1M | $13.7M | ||
| Q1 25 | $22.3M | $11.7M | ||
| Q4 24 | $18.8M | $33.7M | ||
| Q3 24 | $-2.2M | $42.4M | ||
| Q2 24 | $5.2M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $53.3M | $42.2M | ||
| Q3 25 | $33.0M | $21.2M | ||
| Q2 25 | $27.9M | $5.6M | ||
| Q1 25 | $22.2M | $2.1M | ||
| Q4 24 | $18.6M | $18.3M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 26.4% | 20.9% | ||
| Q3 25 | 18.2% | 9.8% | ||
| Q2 25 | 17.8% | 2.8% | ||
| Q1 25 | 16.1% | 1.1% | ||
| Q4 24 | 15.2% | 9.5% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.4% | 3.6% | ||
| Q2 25 | 0.1% | 4.0% | ||
| Q1 25 | 0.1% | 5.0% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 0.0% | 8.2% | ||
| Q2 24 | 0.0% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | 3.80× | 10.20× | ||
| Q3 25 | 1.83× | 3.36× | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 2.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
